K-numberK253754
Device namePhilips Lumea IPL
ApplicantPhilips Consumer Lifestyle B.V.
Product codeOHT
Device classClass II
Decision dateDec 23, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Philips Lumea IPL is an over-the-counter, hand-held device that uses intense pulsed light to remove unwanted hair and permanently reduce hair regrowth in users aged 18–65 years with fair to medium brown skin tones and naturally dark blond to black hair. The device is intended for single-user, multiple-use application in a home environment and works by emitting spectrally adjusted light absorbed by melanin, causing hair to shed and growth to be delayed or inhibited.

Technological characteristics

The subject device (9900 Pro) is nearly identical to the predicate (K243453) in core specifications: both use a xenon arc flashlamp, emit 520–1200 nm light at 6 J/cm² maximum energy density, and include identical spot sizes and pulse durations. Key additions in the subject device are Bluetooth Low Energy connectivity with mobile app integration, real-time motion guidance via inertial measurement sensors, and over-the-air software updates—features marked as 'equivalent' rather than identical because they enhance usability without changing the fundamental operating principle or safety profile.

Test standards cited

The device was tested against IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-1-11, IEC 60601-2-57, IEC 60601-2-83, IEC 62304, IEC 62366-1, ISO 10993-1, ISO 10993-5, ISO 10993-10, and ISTA 3A for shipping; software verification and validation were conducted per FDA's 2023 guidance on device software functions.

Substantial equivalence argument

The subject device is substantially equivalent to the predicate because both share identical classification, indications for use (unwanted hair removal and permanent reduction of regrowth), design principle (intense pulsed light), user group (18–65 years), intended environment (home use), and core safety features (skin and skin-tone detection sensors). The differences—wireless connectivity, motion guidance, and software updates—are additions that do not alter the fundamental technological characteristics or create new safety concerns, as they are supported by equivalent testing and compliance with all applicable standards.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →